Neurogene Inc. (NASDAQ:NGNE) Receives $60.83 Consensus PT from Analysts
Shares of Neurogene Inc. (NASDAQ:NGNE – Get Free Report) have been assigned a consensus rating of “Buy” from the eight research firms that are currently covering the firm, MarketBeat.com reports. Seven analysts have rated the stock with a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12 month […]
More Stories
North Korea Threatens Stronger Deterrence Ahead of US–South Korea Military Drills
By Victoria Friedman Pyongyang has denounced the upcoming annual joint U.S.–South Korean military drills on the peninsula, calling them provocative...
Trump Says He’ll Declare the Hormuz Strait a US Territory ‘Pretty Soon’
By Emel Akan President Donald Trump announced on Friday his intention to declare the Strait of Hormuz a U.S. territory,...
Hurricane Watch Issued for Hawaii’s Big Island as Tropical Storm Lala Forms
By Savannah Hulsey Pointer A hurricane watch has been issued for the Big Island of Hawaii as Tropical Storm Lala...
Earnings Are Up Over 50% So Far
By Louis Navellier Through last Friday, 88% of the S&P 500 companies have announced second-quarter results. According to FactSet Earnings...
Trump Orders Navy to Replace Newer Fighter Launch System With Older Steam Catapults
By Timothy Frudd President Donald Trump ordered the Navy on Aug. 13 to return to using steam catapults to launch...
Trade Court Upholds Trump’s Shutdown of $800 De Minimis Duty Exemption
By Matthew Vadum The U.S. Court of International Trade on Aug. 13 upheld the Trump administration’s authority to end the...